• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Z1071标准的应用:新辅助化疗后初始淋巴结阳性乳腺癌腋窝淋巴结的超声分类

Application of the Z1071 criteria: classification of axillary lymph nodes on ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer.

作者信息

Iwamoto Naoko, Miyamoto Hiromi, Horiguchi Shinichiro, Honda Yayoi, Aruga Tomoyuki

机构信息

Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan.

出版信息

J Med Ultrason (2001). 2020 Apr;47(2):299-303. doi: 10.1007/s10396-020-01010-0. Epub 2020 Feb 29.

DOI:10.1007/s10396-020-01010-0
PMID:32112307
Abstract

PURPOSE

The American College of Surgeons Oncology Group (ACOSOG) Z1071 trial assessed the accuracy of sentinel lymph node biopsies in clinically node-positive patients who underwent neoadjuvant chemotherapy (NAC). Axillary ultrasound (US) images after NAC were reviewed, and the accuracy of classifying nodes into six types according to the ACOSOG Z1071 trial was determined.

METHODS

This study included 69 patients who underwent NAC followed by curative surgery for breast cancer including axillary lymph node dissection between January 2010 and July 2019. All patients were pathologically confirmed as being initially node positive. Lymph nodes were retrospectively classified into one of six types based on the appearance of the nodal cortex and hilum. Types I and II were classified as having normal nodal morphology, whereas types III, IV, V, and VI were classified as having suspicious nodal morphology. These node types on US images after NAC were compared between patients with an axillary complete response (Ax-pCR) and those with residual metastatic lymph nodes (Ax-non-pCR) using Chi-square tests.

RESULTS

Twenty-four (35%) of the 69 patients achieved Ax-pCR. Patients with nodes classified as type I or II were more likely to achieve Ax-pCR (83% vs. 36%, p = 0. 0002).

CONCLUSION

The classification of six node types was associated with nodal status.

摘要

目的

美国外科医师学会肿瘤学组(ACOSOG)Z1071试验评估了前哨淋巴结活检在接受新辅助化疗(NAC)的临床淋巴结阳性患者中的准确性。回顾了NAC后的腋窝超声(US)图像,并根据ACOSOG Z1071试验将淋巴结分为六种类型的准确性进行了测定。

方法

本研究纳入了2010年1月至2019年7月期间接受NAC随后进行乳腺癌根治性手术(包括腋窝淋巴结清扫)的69例患者。所有患者经病理证实最初为淋巴结阳性。根据淋巴结皮质和门部的外观,将淋巴结回顾性地分为六种类型之一。I型和II型被分类为具有正常的淋巴结形态,而III型、IV型、V型和VI型被分类为具有可疑的淋巴结形态。使用卡方检验比较了腋窝完全缓解(Ax-pCR)患者和有残留转移性淋巴结(Ax-non-pCR)患者在NAC后US图像上的这些淋巴结类型。

结果

69例患者中有24例(35%)实现了Ax-pCR。被分类为I型或II型淋巴结的患者更有可能实现Ax-pCR(83%对36%,p = 0.0002)。

结论

六种淋巴结类型的分类与淋巴结状态相关。

相似文献

1
Application of the Z1071 criteria: classification of axillary lymph nodes on ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer.Z1071标准的应用:新辅助化疗后初始淋巴结阳性乳腺癌腋窝淋巴结的超声分类
J Med Ultrason (2001). 2020 Apr;47(2):299-303. doi: 10.1007/s10396-020-01010-0. Epub 2020 Feb 29.
2
Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).新辅助化疗后的腋窝超声及其对前哨淋巴结手术的影响:美国外科医师学会肿瘤学组Z1071试验(联盟)的结果
J Clin Oncol. 2015 Oct 20;33(30):3386-93. doi: 10.1200/JCO.2014.57.8401. Epub 2015 Feb 2.
3
Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).腋窝超声可识别化疗后残留的淋巴结疾病:美国外科医师学院肿瘤学组 Z1071 试验(Alliance)的结果。
AJR Am J Roentgenol. 2018 Mar;210(3):669-676. doi: 10.2214/AJR.17.18295. Epub 2018 Jan 30.
4
Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.新辅助化疗后腋窝手术治疗阳性淋巴结乳腺癌患者的应用模式:国家癌症数据库(NCDB)分析。
Ann Surg Oncol. 2019 Oct;26(10):3305-3311. doi: 10.1245/s10434-019-07540-3. Epub 2019 Jul 24.
5
Use of ultrasound and MRI to stage the axilla for breast cancer before and after neoadjuvant chemotherapy prior to targeted sentinel lymphadenectomy.使用超声和 MRI 在新辅助化疗前和靶向前哨淋巴结活检前对乳腺癌进行腋窝分期。
Breast Cancer Res Treat. 2024 Aug;206(3):595-602. doi: 10.1007/s10549-024-07332-8. Epub 2024 May 3.
6
Application of ACOSOG Z1071: Effect of Results on Patient Care and Surgical Decision-Making.ACOSOG Z1071 的应用:结果对患者护理和手术决策的影响。
Clin Breast Cancer. 2018 Aug;18(4):270-275. doi: 10.1016/j.clbc.2017.10.006. Epub 2017 Oct 12.
7
Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.乳腺癌新辅助化疗后的腋窝分期:一项将前哨淋巴结活检与治疗前阳性腋窝淋巴结放射性粒子定位相结合的初步研究。
Ann Surg Oncol. 2016 May;23(5):1549-53. doi: 10.1245/s10434-015-5052-8. Epub 2016 Jan 4.
8
Axillary Nodal Burden Assessed with Pretreatment Breast MRI Is Associated with Failed Sentinel Lymph Node Identification after Neoadjuvant Chemotherapy for Breast Cancer.术前乳腺 MRI 评估腋窝淋巴结受累与乳腺癌新辅助化疗后前哨淋巴结定位失败相关。
Radiology. 2020 May;295(2):275-282. doi: 10.1148/radiol.2020191639. Epub 2020 Mar 3.
9
Management of the axilla after neoadjuvant chemotherapy for clinically node positive breast cancer: A nationwide survey study in The Netherlands.临床淋巴结阳性乳腺癌新辅助化疗后腋窝的管理:荷兰的一项全国性调查研究
Eur J Surg Oncol. 2016 Jul;42(7):956-64. doi: 10.1016/j.ejso.2016.03.023. Epub 2016 Apr 12.
10
The Relevance of Ultrasound Imaging of Suspicious Axillary Lymph Nodes and Fine-needle Aspiration Biopsy in the Post-ACOSOG Z11 Era in Early Breast Cancer.超声成像对可疑腋窝淋巴结的相关性及细针穿刺活检在早期乳腺癌ACOSOG Z11时代后的应用
Acad Radiol. 2017 Mar;24(3):308-315. doi: 10.1016/j.acra.2016.10.005. Epub 2016 Dec 1.

本文引用的文献

1
Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy.新辅助化疗后乳腺病理完全缓解对腋窝病理反应的预测。
Breast Cancer Res Treat. 2019 Aug;176(3):591-596. doi: 10.1007/s10549-019-05214-y. Epub 2019 May 7.
2
Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype.原发系统性治疗后前哨淋巴结活检在阳性淋巴结乳腺癌患者中的应用:时间趋势、影像学分期能力以及根据分子亚型的淋巴结降期。
Eur J Surg Oncol. 2019 Jun;45(6):969-975. doi: 10.1016/j.ejso.2019.01.219. Epub 2019 Jan 31.
3
The influence of breast cancer subtypes on axillary ultrasound accuracy: A retrospective single center analysis of 583 women.
乳腺癌亚型对腋窝超声准确性的影响:583 例女性回顾性单中心分析。
Eur J Surg Oncol. 2019 Apr;45(4):538-543. doi: 10.1016/j.ejso.2018.10.001. Epub 2018 Oct 10.
4
Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).腋窝超声可识别化疗后残留的淋巴结疾病:美国外科医师学院肿瘤学组 Z1071 试验(Alliance)的结果。
AJR Am J Roentgenol. 2018 Mar;210(3):669-676. doi: 10.2214/AJR.17.18295. Epub 2018 Jan 30.
5
A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer.乳腺癌新辅助化疗后腋窝淋巴结病理完全缓解的预测模型。
Ann Surg Oncol. 2018 May;25(5):1304-1311. doi: 10.1245/s10434-018-6345-5. Epub 2018 Jan 24.
6
The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT).超声在新辅助化疗(NACT)后腋窝临床再分期中的应用。
Breast. 2017 Oct;35:104-108. doi: 10.1016/j.breast.2017.05.015. Epub 2017 Jul 11.
7
Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trial.使用超声和触诊预测新辅助化疗后腋窝淋巴结状态——多中心SENTINA试验结果
Breast. 2017 Feb;31:202-207. doi: 10.1016/j.breast.2016.11.012. Epub 2016 Nov 24.
8
Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer.预测临床淋巴结阳性乳腺癌患者新辅助化疗腋窝反应的列线图
Ann Surg Oncol. 2016 Oct;23(11):3501-3509. doi: 10.1245/s10434-016-5277-1. Epub 2016 May 23.
9
Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer.用于预测经细胞学证实的淋巴结阳性乳腺癌新辅助化疗后腋窝病理完全缓解的预后列线图
Medicine (Baltimore). 2015 Oct;94(43):e1720. doi: 10.1097/MD.0000000000001720.
10
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.新辅助化疗后活检证实淋巴结阳性乳腺癌前哨淋巴结活检:SN FNAC 研究。
J Clin Oncol. 2015 Jan 20;33(3):258-64. doi: 10.1200/JCO.2014.55.7827. Epub 2014 Dec 1.